Clinical Trials Logo

Clinical Trial Summary

Low dose of aspirin is the main cause of gastro-duodenal ulcer. The best prevention is not definite particularly in patients without history of ulcer and infected by H. pylori.The aim of the study is to evaluate the gastric damage induced by aspirin in patients with H. pylori infection but who have any history of ulcer.


Clinical Trial Description

The aim of the study is to compare the protective effect of H. pylori eradication versus Pantoprazole versus placebo on the gastric damage induced by low dose of aspirin. Treatment are attributed by randomisation. Patients are followed for 6 months and gastric damage are evaluated by endoscopy at the end of this period. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00713947
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Withdrawn
Phase Phase 4
Start date April 2008
Completion date March 2010

See also
  Status Clinical Trial Phase
Completed NCT01274234 - OCT Evaluation of Healing of COMBO Stent Phase 1/Phase 2
Not yet recruiting NCT02591264 - Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3 N/A
Completed NCT03034148 - Platelet Acetyl Coenzyme A Carboxylase Phosphorylation in Coronary Artery Disease N/A
Completed NCT00657436 - Myeloid-Related Protein in Evaluation of Acute Chest Pain in the Emergency Departement N/A
Completed NCT00714623 - The SCRIPPS DES REAL WORLD Registry N/A
Recruiting NCT00327041 - Monitoring Response to Antiplatelet Therapy Phase 4
Completed NCT03180931 - Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis N/A
Not yet recruiting NCT05647018 - In-hospital Clinical Outcome of Deferred Stenting Versus Immediate Stenting in the Management of Acute STEMI Presenting With High Thrombus Burden. Phase 2
Completed NCT00963781 - Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Phase 4
Completed NCT01166685 - Safety and Efficacy Study Comparing 3 New Types of Coronary Stents Phase 4